The Hippocampus in Patients Treated With Electroconvulsive Therapy

Authors:
  • DBDieter F. Braus
    Dieter F. Braus
  • SWSigrid Walter
    Sigrid Walter
  • WWWolfgang Weber-Fahr
    Wolfgang Weber-Fahr

Abstract
ELECTROCONVULSIVE therapy (ECT) is highly effective in the treatment of major depression and other selective psychiatric disorders. Nevertheless, ECT remains controversial because of its cognitive side effects and its unknown effects on cerebral function.1,2 Structural brain imaging and postmortem neuropathologic studies,2-5 however, provided no evidence that ECT produces brain damage. Human brain imaging studies are limited in their spatial resolution and cannot detect neuronal damage at the cellular level. Measurements of water T2 relaxation times showed a significant increase in T2 in the thalamus after ECT.6 It has been observed7 that after ECT, acetylcholine levels in cerebrospinal fluid rise, accompanied by increased activity of cholinesterase in cerebrospinal fluid and blood. Results of recent animal studies8-10 have shown that mossy fiber sprouting in limbic brain regions is induced by multiple ECT treatments. To our knowledge, no magnetic resonance spectroscopic imaging (MRSI) studies have been reported monitoring the effects of ECT on the hippocampus. Three single-voxel hydrogen 1 (1H) and phosphorus 31 studies11-13 have reported pre- and post-ECT spectra in other brain regions, and the 1H MRSI studies were aimed at lactate detection after ECT.

This publication has 27 references indexed in Scilit: